1. Treatment With Anti–Tumor Necrosis Factor Biologic Agents in Human T Lymphotropic Virus Type I–Positive Patients With Rheumatoid Arthritis. Issue 5 (May 2014) Authors: Umekita, Kunihiko; Hidaka, Toshihiko; Miyauchi, Shunichi; Ueno, Shiro; Kubo, Kazuyoshi; Takajo, Ichiro; Hashiba, Yayoi; Kai, Yasufumi; Nagatomo, Yasuhiro; Okayama, Akihiko Journal: Arthritis care & research Issue: Volume 66:Issue 5(2014:May) Page Start: 788 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Use of anti-tumor necrosis factor biologics in the treatment of rheumatoid arthritis does not change human T-lymphotropic virus type 1 markers: a case series. Issue 5 (September 2015) Authors: Umekita, Kunihiko; Umeki, Kazumi; Miyauchi, Shunichi; Ueno, Shiro; Kubo, Kazuyoshi; Kusumoto, Norio; Takajo, Ichiro; Nagatomo, Yasuhiro; Okayama, Akihiko Journal: Modern rheumatology Issue: Volume 25:Issue 5(2015) Page Start: 794 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗